A Study of Ivonescimab in First-Line ES-SCLC

Clinical trial NCT07245446 · RECRUITING

Trial details

NCT number: NCT07245446
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Start date: 2025-10-29
Primary completion: 2027-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.